MAP Pharmaceuticals (NASDAQ:MAPP)
Pharmaceutical Preparations
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
genedom
(98.17)
Submitted: 3/28/2012 12:48:56 AM :
Start Price:
$16.34
MAPP Score:
+19.26
There will be a long way, if any, for MAPP to get its drug approval. Who has the patience? Not Wall Street.
Recs
StockTraderG
(78.88)
Submitted: 3/26/2012 12:31:40 PM :
Start Price:
$16.85
MAPP Score:
+21.68
Betting against approval. And even if MAPP is approved, I feel that the current stock price already prices in that result
Recs
TMFBiologyFool
(98.28)
Submitted: 3/23/2012 2:54:30 PM :
Start Price:
$16.10
MAPP Score:
-19.11
Still risky, but it looks like an approval is more likely than not.
Recs
acts20
(37.40)
Submitted: 3/22/2012 1:51:57 PM :
Start Price:
$16.26
MAPP Score:
-20.13
shoe in to pass?
Recs
PDTBiotech
(95.06)
Submitted: 3/21/2012 11:50:46 AM :
Start Price:
$15.21
MAPP Score:
-14.33
Spec bet - PDUFA Monday.
Recs
withoutlimits
(84.28)
Submitted: 9/25/2010 3:40:15 AM :
Start Price:
$15.30
MAPP Score:
+35.60
drug pushers
Recs
SorosPosTrader
(36.62)
Submitted: 3/9/2010 10:47:14 AM :
Start Price:
$15.52
MAPP Score:
+37.05
on 4th March 200,000 shares were disposed.
Now holding 2.9 m shares
Recs
SorosTracking
(58.49)
Submitted: 2/22/2010 8:01:19 AM :
Start Price:
$14.00
MAPP Score:
-31.64
4,076,169 owned
- Q409 13F - Soros Fund Management LLC
Recs
megainstincts
(< 20)
Submitted: 2/3/2010 5:00:49 PM :
Start Price:
$16.36
MAPP Score:
-46.95
Niche product in a large unmet need market
Recs
ABrowning1987
(< 20)
Submitted: 8/27/2009 10:43:58 PM :
Start Price:
$9.36
MAPP Score:
+2.47
I really like this stock if the company continue to grows and present new products. Stock price is 9.33, and should continue to go up and down for the next few weeks. I believe in the new year the stock can hit around 15 to 20 dollars.
Recs
Nmendez10
(41.68)
Submitted: 5/30/2009 1:01:41 PM :
Start Price:
$11.96
MAPP Score:
-40.91
Their drugs have been performing well in clinical trials lately.
Recs
PhillyDan
(84.49)
Submitted: 5/27/2009 2:09:58 PM :
Start Price:
$12.93
MAPP Score:
-53.79
New migrane drug will get FDA approval.
Recs
Ineedmoney101
(< 20)
Submitted: 2/24/2009 3:01:14 PM :
Start Price:
$2.75
MAPP Score:
+267.93
Wow! Ridiculously oversold i'm so mad that i don't have ANY spare money not invested already i would buy as many of these as possible right now.
Recs
007CPA
(87.07)
Submitted: 2/24/2009 2:03:52 PM :
Start Price:
$2.55
MAPP Score:
+301.39
Oversold, down 75%
Recs
boater9384
(< 20)
Submitted: 4/2/2008 9:08:13 PM :
Start Price:
$14.19
MAPP Score:
-15.10
Soros holding, good drug trials, nice potential - may not pay out but a good CAPS speculative play.
Recs
ZeroSignal
(42.21)
Submitted: 4/1/2008 5:59:35 AM :
Start Price:
$14.00
MAPP Score:
-15.69
1. Two drugs in phase three trials, both with promising clinical results
2. Lots of cash on hand
3. George Soros is one of their largest investors; he was wrong on CountryWide, but the man has been Buffet-like on almost everything else
Long on MAPP
Recs
JInvestments
(87.55)
Submitted: 3/30/2008 10:27:25 PM :
Start Price:
$13.31
MAPP Score:
-13.06
Stage 3
Recs
ScotSAK
(49.57)
Submitted: 10/19/2007 2:04:28 AM :
Start Price:
$14.96
MAPP Score:
-9.19
A change in the trend of the RSI and a gradual increase in accummulation would indicate that this one is about to turn back up.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 18 of 18